Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1678 entries
Sorted by: Best Match Show Resources per page
Pressure-dependent reversible increase in T(c) for the ferrimagnetic 2-D Mn(II)(TCNE)I(OH2) and 3-D Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF organic-based magnets.

Inorganic chemistry

DaSilva JG, McConnell AC, Miller JS.
PMID: 23537424
Inorg Chem. 2013 Apr 15;52(8):4629-34. doi: 10.1021/ic400250n. Epub 2013 Mar 28.

The pressure dependence of the magnetic properties of ferrimagnetic Mn(II)(TCNE)I(OH2) up to 14.05 kbar and Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF up to 14.32 kbar were studied. For Mn(II)(TCNE)I(OH2), two distinct pressure regions separated at ∼1 kbar were evident in both the temperature and...

Cite
DaSilva JG, McConnell AC, Miller JS. Pressure-dependent reversible increase in T(c) for the ferrimagnetic 2-D Mn(II)(TCNE)I(OH2) and 3-D Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF organic-based magnets. Inorg Chem. 2013;52(8):4629-34doi: 10.1021/ic400250n.
DaSilva, J. G., McConnell, A. C., & Miller, J. S. (2013). Pressure-dependent reversible increase in T(c) for the ferrimagnetic 2-D Mn(II)(TCNE)I(OH2) and 3-D Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF organic-based magnets. Inorganic chemistry, 52(8), 4629-34. https://doi.org/10.1021/ic400250n
DaSilva, Jack G, et al. "Pressure-dependent reversible increase in T(c) for the ferrimagnetic 2-D Mn(II)(TCNE)I(OH2) and 3-D Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF organic-based magnets." Inorganic chemistry vol. 52,8 (2013): 4629-34. doi: https://doi.org/10.1021/ic400250n
DaSilva JG, McConnell AC, Miller JS. Pressure-dependent reversible increase in T(c) for the ferrimagnetic 2-D Mn(II)(TCNE)I(OH2) and 3-D Mn(II)(TCNE)(3/2)(I3)(1/2)·zTHF organic-based magnets. Inorg Chem. 2013 Apr 15;52(8):4629-34. doi: 10.1021/ic400250n. Epub 2013 Mar 28. PMID: 23537424.
Copy Download .nbib Format: NLM
Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population.

Tobacco control

Pearson AL, Cleghorn CL, van der Deen FS, Cobiac LJ, Kvizhinadze G, Nghiem N, Blakely T, Wilson N.
PMID: 27660112
Tob Control. 2016 Sep 22; doi: 10.1136/tobaccocontrol-2015-052846. Epub 2016 Sep 22.

BACKGROUND: Since there is some evidence that the density and distribution of tobacco retail outlets may influence smoking behaviours, we aimed to estimate the impacts of 4 tobacco outlet reduction interventions in a country with a smoke-free goal: New...

Cite
Pearson AL, Cleghorn CL, van der Deen FS, et al. Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population. Tob Control. 2016;doi: 10.1136/tobaccocontrol-2015-052846.
Pearson, A. L., Cleghorn, C. L., van der Deen, F. S., Cobiac, L. J., Kvizhinadze, G., Nghiem, N., Blakely, T., & Wilson, N. (2016). Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population. Tobacco control, . https://doi.org/10.1136/tobaccocontrol-2015-052846
Pearson, Amber L, et al. "Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population." Tobacco control vol. (2016). doi: https://doi.org/10.1136/tobaccocontrol-2015-052846
Pearson AL, Cleghorn CL, van der Deen FS, Cobiac LJ, Kvizhinadze G, Nghiem N, Blakely T, Wilson N. Tobacco retail outlet restrictions: health and cost impacts from multistate life-table modelling in a national population. Tob Control. 2016 Sep 22; doi: 10.1136/tobaccocontrol-2015-052846. Epub 2016 Sep 22. PMID: 27660112.
Copy Download .nbib Format: NLM
Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study.

Journal of personalized medicine

Fu MR, Axelrod D, Guth AA, Fletcher J, Qiu JM, Scagliola J, Kleinman R, Ryan CE, Chan N, Haber J.
PMID: 26404383
J Pers Med. 2015 Sep 03;5(3):326-40. doi: 10.3390/jpm5030326.

Obesity is one of the risk factors for developing lymphedema following breast cancer treatment. We prospectively enrolled 140 women and followed the participants for 12 months after surgery to investigate patterns of obesity and lymph fluid level in the...

Cite
Fu MR, Axelrod D, Guth AA, et al. Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study. J Pers Med. 2015;5(3):326-40doi: 10.3390/jpm5030326.
Fu, M. R., Axelrod, D., Guth, A. A., Fletcher, J., Qiu, J. M., Scagliola, J., Kleinman, R., Ryan, C. E., Chan, N., & Haber, J. (2015). Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study. Journal of personalized medicine, 5(3), 326-40. https://doi.org/10.3390/jpm5030326
Fu, Mei R, et al. "Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study." Journal of personalized medicine vol. 5,3 (2015): 326-40. doi: https://doi.org/10.3390/jpm5030326
Fu MR, Axelrod D, Guth AA, Fletcher J, Qiu JM, Scagliola J, Kleinman R, Ryan CE, Chan N, Haber J. Patterns of Obesity and Lymph Fluid Level during the First Year of Breast Cancer Treatment: A Prospective Study. J Pers Med. 2015 Sep 03;5(3):326-40. doi: 10.3390/jpm5030326. PMID: 26404383; PMCID: PMC4600151.
Copy Download .nbib Format: NLM
Reducing translation through eIF4G/IFG-1 improves survival under ER stress that depends on heat shock factor HSF-1 in Caenorhabditis elegans.

Aging cell

Howard AC, Rollins J, Snow S, Castor S, Rogers AN.
PMID: 27538368
Aging Cell. 2016 Dec;15(6):1027-1038. doi: 10.1111/acel.12516. Epub 2016 Aug 18.

Although certain methods of lowering and/or altering mRNA translation are associated with increased lifespan, the mechanisms underlying this effect remain largely unknown. We previously showed that the increased lifespan conferred by reducing expression of eukaryotic translation initiation factor 4G...

Cite
Howard AC, Rollins J, Snow S, et al. Reducing translation through eIF4G/IFG-1 improves survival under ER stress that depends on heat shock factor HSF-1 in Caenorhabditis elegans. Aging Cell. 2016;15(6):1027-1038doi: 10.1111/acel.12516.
Howard, A. C., Rollins, J., Snow, S., Castor, S., & Rogers, A. N. (2016). Reducing translation through eIF4G/IFG-1 improves survival under ER stress that depends on heat shock factor HSF-1 in Caenorhabditis elegans. Aging cell, 15(6), 1027-1038. https://doi.org/10.1111/acel.12516
Howard, Amber C, et al. "Reducing translation through eIF4G/IFG-1 improves survival under ER stress that depends on heat shock factor HSF-1 in Caenorhabditis elegans." Aging cell vol. 15,6 (2016): 1027-1038. doi: https://doi.org/10.1111/acel.12516
Howard AC, Rollins J, Snow S, Castor S, Rogers AN. Reducing translation through eIF4G/IFG-1 improves survival under ER stress that depends on heat shock factor HSF-1 in Caenorhabditis elegans. Aging Cell. 2016 Dec;15(6):1027-1038. doi: 10.1111/acel.12516. Epub 2016 Aug 18. PMID: 27538368; PMCID: PMC5114698.
Copy Download .nbib Format: NLM
Catalytic enantio- and diastereoselective Mannich reaction of α-substituted isocyanoacetates and ketimines.

Chemical communications (Cambridge, England)

de la Campa R, Gammack Yamagata AD, Ortín I, Franchino A, Thompson AL, Odell B, Dixon DJ.
PMID: 27500289
Chem Commun (Camb). 2016 Aug 23;52(70):10632-5. doi: 10.1039/c6cc04132a.

The highly diastereo- and enantioselective Mannich addition/cyclisation reaction of α-substituted isocyanoacetate ester pronucleophiles and (hetero)aryl and alkyl methyl ketone-derived ketimines using a silver acetate and a cinchona-derived amino phosphine binary catalyst system is reported.

Cite
de la Campa R, Gammack Yamagata AD, Ortín I, et al. Catalytic enantio- and diastereoselective Mannich reaction of α-substituted isocyanoacetates and ketimines. Chem Commun (Camb). 2016;52(70):10632-5doi: 10.1039/c6cc04132a.
de la Campa, R., Gammack Yamagata, A. D., Ortín, I., Franchino, A., Thompson, A. L., Odell, B., & Dixon, D. J. (2016). Catalytic enantio- and diastereoselective Mannich reaction of α-substituted isocyanoacetates and ketimines. Chemical communications (Cambridge, England), 52(70), 10632-5. https://doi.org/10.1039/c6cc04132a
de la Campa, Raquel, et al. "Catalytic enantio- and diastereoselective Mannich reaction of α-substituted isocyanoacetates and ketimines." Chemical communications (Cambridge, England) vol. 52,70 (2016): 10632-5. doi: https://doi.org/10.1039/c6cc04132a
de la Campa R, Gammack Yamagata AD, Ortín I, Franchino A, Thompson AL, Odell B, Dixon DJ. Catalytic enantio- and diastereoselective Mannich reaction of α-substituted isocyanoacetates and ketimines. Chem Commun (Camb). 2016 Aug 23;52(70):10632-5. doi: 10.1039/c6cc04132a. PMID: 27500289.
Copy Download .nbib Format: NLM
Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction.

Radiology case reports

Frank AA, Morse MD, Smith BR, Shaffer K.
PMID: 27303542
Radiol Case Rep. 2015 Nov 06;3(3):189. doi: 10.2484/rcr.v3i3.189. eCollection 2008.

We report a case of autoimmune pancreatitis in a 31-year-old man with signs and symptoms of biliary tract obstruction. Evaluation with sonography, computed tomography, and ultimately endoscopic retrograde cholangiopancreatography, demonstrated a 5 by 2 cm hypoechoic, hypodense mass near...

Cite
Frank AA, Morse MD, Smith BR, et al. Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction. Radiol Case Rep. 2015;3(3):189doi: 10.2484/rcr.v3i3.189.
Frank, A. A., Morse, M. D., Smith, B. R., & Shaffer, K. (2008). Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction. Radiology case reports, 3(3), 189. https://doi.org/10.2484/rcr.v3i3.189
Frank, Amber A, et al. "Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction." Radiology case reports vol. 3,3 (2008): 189. doi: https://doi.org/10.2484/rcr.v3i3.189
Frank AA, Morse MD, Smith BR, Shaffer K. Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction. Radiol Case Rep. 2015 Nov 06;3(3):189. doi: 10.2484/rcr.v3i3.189. eCollection 2008. PMID: 27303542; PMCID: PMC4897013.
Copy Download .nbib Format: NLM
Activating mutation of .

Oncotarget

Fu X, Niu W, Li J, Kiliti AJ, Al-Ahmadie HA, Iyer G, Gao SP, Li Q.
PMID: 29113426
Oncotarget. 2017 Sep 07;8(46):81709-81716. doi: 10.18632/oncotarget.20700. eCollection 2017 Oct 06.

Cardiac sarcoma is a rare malignant tumor with undefined genetic mutations and no targeted therapy. Here in one rare case of undifferentiated cardiac intimal sarcoma (IS), a next-generation sequencing based assay, MSK-IMPACT (Memorial Sloan Kettering - Integrated Mutation Profiling...

Cite
Fu X, Niu W, Li J, et al. Activating mutation of . Oncotarget. 2017;8(46):81709-81716doi: 10.18632/oncotarget.20700.
Fu, X., Niu, W., Li, J., Kiliti, A. J., Al-Ahmadie, H. A., Iyer, G., Gao, S. P., & Li, Q. (2017). Activating mutation of . Oncotarget, 8(46), 81709-81716. https://doi.org/10.18632/oncotarget.20700
Fu, Xiaoling, et al. "Activating mutation of ." Oncotarget vol. 8,46 (2017): 81709-81716. doi: https://doi.org/10.18632/oncotarget.20700
Fu X, Niu W, Li J, Kiliti AJ, Al-Ahmadie HA, Iyer G, Gao SP, Li Q. Activating mutation of . Oncotarget. 2017 Sep 07;8(46):81709-81716. doi: 10.18632/oncotarget.20700. eCollection 2017 Oct 06. PMID: 29113426; PMCID: PMC5655321.
Copy Download .nbib Format: NLM
A phase I clinical study to evaluate safety of orally administered, genetically engineered .

Veterinary medicine and science

Fritz SE, Henson MS, Greengard E, Winter AL, Stuebner KM, Yoon U, Wilk VL, Borgatti A, Augustin LB, Modiano JF, Saltzman DA.
PMID: 29067193
Vet Med Sci. 2016 Jun 06;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug.

We conducted a prospective phase I study to evaluate safety of an orally administered

Cite
Fritz SE, Henson MS, Greengard E, et al. A phase I clinical study to evaluate safety of orally administered, genetically engineered . Vet Med Sci. 2016;2(3):179-190doi: 10.1002/vms3.32.
Fritz, S. E., Henson, M. S., Greengard, E., Winter, A. L., Stuebner, K. M., Yoon, U., Wilk, V. L., Borgatti, A., Augustin, L. B., Modiano, J. F., & Saltzman, D. A. (2016). A phase I clinical study to evaluate safety of orally administered, genetically engineered . Veterinary medicine and science, 2(3), 179-190. https://doi.org/10.1002/vms3.32
Fritz, Sara E, et al. "A phase I clinical study to evaluate safety of orally administered, genetically engineered ." Veterinary medicine and science vol. 2,3 (2016): 179-190. doi: https://doi.org/10.1002/vms3.32
Fritz SE, Henson MS, Greengard E, Winter AL, Stuebner KM, Yoon U, Wilk VL, Borgatti A, Augustin LB, Modiano JF, Saltzman DA. A phase I clinical study to evaluate safety of orally administered, genetically engineered . Vet Med Sci. 2016 Jun 06;2(3):179-190. doi: 10.1002/vms3.32. eCollection 2016 Aug. PMID: 29067193; PMCID: PMC5645873.
Copy Download .nbib Format: NLM
Crystal structure of 2-azido-1,3-bis-(2,6-diiso-propyl-phen-yl)-1,3,2-di-aza-phospho-lidine.

Acta crystallographica. Section E, Crystallographic communications

Veinot AJ, Blair AD, Masuda JD.
PMID: 28638656
Acta Crystallogr E Crystallogr Commun. 2017 May 31;73:905-907. doi: 10.1107/S2056989017007642. eCollection 2017 Jun 01.

The title compound, C

Cite
Veinot AJ, Blair AD, Masuda JD. Crystal structure of 2-azido-1,3-bis-(2,6-diiso-propyl-phen-yl)-1,3,2-di-aza-phospho-lidine. Acta Crystallogr E Crystallogr Commun. 2017;73:905-907doi: 10.1107/S2056989017007642.
Veinot, A. J., Blair, A. D., & Masuda, J. D. (2017). Crystal structure of 2-azido-1,3-bis-(2,6-diiso-propyl-phen-yl)-1,3,2-di-aza-phospho-lidine. Acta crystallographica. Section E, Crystallographic communications, 73905-907. https://doi.org/10.1107/S2056989017007642
Veinot, Alex J, et al. "Crystal structure of 2-azido-1,3-bis-(2,6-diiso-propyl-phen-yl)-1,3,2-di-aza-phospho-lidine." Acta crystallographica. Section E, Crystallographic communications vol. 73 (2017): 905-907. doi: https://doi.org/10.1107/S2056989017007642
Veinot AJ, Blair AD, Masuda JD. Crystal structure of 2-azido-1,3-bis-(2,6-diiso-propyl-phen-yl)-1,3,2-di-aza-phospho-lidine. Acta Crystallogr E Crystallogr Commun. 2017 May 31;73:905-907. doi: 10.1107/S2056989017007642. eCollection 2017 Jun 01. PMID: 28638656; PMCID: PMC5458321.
Copy Download .nbib Format: NLM
Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Al-Sweedan SA, Jaradat S, Amer K, Hayajneh W, Haddad H.
PMID: 27263941
Turk J Haematol. 2011 Mar 05;28(1):47-51. doi: 10.5152/tjh.2011.05.

OBJECTIVE: The main objectives of this study are to investigate the prevalence of HCV among patients with β-thalassemia major and to determine the most prevalent genotype for this virus among them.METHODS: One hundred twenty-two β-thalassemia major patients who were...

Cite
Al-Sweedan SA, Jaradat S, Amer K, et al. Multipl transfüzyon uygulanan β-talasemi majörlü Ürdünlü hastalarda hepatit C virüsünün seroprevalansı ve genotiplemesi. Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major. Turk J Haematol. 2011;28(1):47-51doi: 10.5152/tjh.2011.05.
Al-Sweedan, S. A., Jaradat, S., Amer, K., Hayajneh, W., & Haddad, H. (2011). Multipl transfüzyon uygulanan β-talasemi majörlü Ürdünlü hastalarda hepatit C virüsünün seroprevalansı ve genotiplemesi. Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major. Turkish journal of haematology : official journal of Turkish Society of Haematology, 28(1), 47-51. https://doi.org/10.5152/tjh.2011.05
Al-Sweedan, Suleimman Ahmad, et al. "Multipl transfüzyon uygulanan β-talasemi majörlü Ürdünlü hastalarda hepatit C virüsünün seroprevalansı ve genotiplemesi." Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 28,1 (2011): 47-51. doi: https://doi.org/10.5152/tjh.2011.05
Al-Sweedan SA, Jaradat S, Amer K, Hayajneh W, Haddad H. Multipl transfüzyon uygulanan β-talasemi majörlü Ürdünlü hastalarda hepatit C virüsünün seroprevalansı ve genotiplemesi. Seroprevalence and genotyping of hepatitis C virus in multiple transfused Jordanian patients with β-thalassemia major. Turk J Haematol. 2011 Mar 05;28(1):47-51. doi: 10.5152/tjh.2011.05. PMID: 27263941.
Copy Download .nbib Format: NLM
Is Word-Problem Solving a Form of Text Comprehension?.

Scientific studies of reading : the official journal of the Society for the Scientific Study of Reading

Fuchs LS, Fuchs D, Compton DL, Hamlett CL, Wang AY.
PMID: 25866461
Sci Stud Read. 2015;19(3):204-223. doi: 10.1080/10888438.2015.1005745.

This study's hypotheses were that (a) word-problem (WP) solving is a form of text comprehension that involves language comprehension processes, working memory, and reasoning, but (b) WP solving differs from other forms of text comprehension by requiring WP-specific language...

Cite
Fuchs LS, Fuchs D, Compton DL, et al. Is Word-Problem Solving a Form of Text Comprehension?. Sci Stud Read. 2015;19(3):204-223doi: 10.1080/10888438.2015.1005745.
Fuchs, L. S., Fuchs, D., Compton, D. L., Hamlett, C. L., & Wang, A. Y. (2015). Is Word-Problem Solving a Form of Text Comprehension?. Scientific studies of reading : the official journal of the Society for the Scientific Study of Reading, 19(3), 204-223. https://doi.org/10.1080/10888438.2015.1005745
Fuchs, Lynn S, et al. "Is Word-Problem Solving a Form of Text Comprehension?." Scientific studies of reading : the official journal of the Society for the Scientific Study of Reading vol. 19,3 (2015): 204-223. doi: https://doi.org/10.1080/10888438.2015.1005745
Fuchs LS, Fuchs D, Compton DL, Hamlett CL, Wang AY. Is Word-Problem Solving a Form of Text Comprehension?. Sci Stud Read. 2015;19(3):204-223. doi: 10.1080/10888438.2015.1005745. PMID: 25866461; PMCID: PMC4391820.
Copy Download .nbib Format: NLM
Returning individual research results for genome sequences of pancreatic cancer.

Genome medicine

Johns AL, Miller DK, Simpson SH, Gill AJ, Kassahn KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Pearson JV, Grimmond SM, Biankin AV, Zeps N.
PMID: 24963353
Genome Med. 2014 May 29;6(5):42. doi: 10.1186/gm558. eCollection 2014.

BACKGROUND: Disclosure of individual results to participants in genomic research is a complex and contentious issue. There are many existing commentaries and opinion pieces on the topic, but little empirical data concerning actual cases describing how individual results have...

Cite
Johns AL, Miller DK, Simpson SH, et al. Returning individual research results for genome sequences of pancreatic cancer. Genome Med. 2014;6(5):42doi: 10.1186/gm558.
Johns, A. L., Miller, D. K., Simpson, S. H., Gill, A. J., Kassahn, K. S., Humphris, J. L., Samra, J. S., Tucker, K., Andrews, L., Chang, D. K., Waddell, N., Pajic, M., Pearson, J. V., Grimmond, S. M., Biankin, A. V., & Zeps, N. (2014). Returning individual research results for genome sequences of pancreatic cancer. Genome medicine, 6(5), 42. https://doi.org/10.1186/gm558
Johns, Amber L, et al. "Returning individual research results for genome sequences of pancreatic cancer." Genome medicine vol. 6,5 (2014): 42. doi: https://doi.org/10.1186/gm558
Johns AL, Miller DK, Simpson SH, Gill AJ, Kassahn KS, Humphris JL, Samra JS, Tucker K, Andrews L, Chang DK, Waddell N, Pajic M, Pearson JV, Grimmond SM, Biankin AV, Zeps N. Returning individual research results for genome sequences of pancreatic cancer. Genome Med. 2014 May 29;6(5):42. doi: 10.1186/gm558. eCollection 2014. PMID: 24963353; PMCID: PMC4067993.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1678 entries